| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression A Sreekumar, LM Poisson, TM Rajendiran, AP Khan, Q Cao, J Yu, ... Nature 457 (7231), 910-914, 2009 | 2479 | 2009 |
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ... Proceedings of the national academy of sciences 100 (20), 11606-11611, 2003 | 1983 | 2003 |
| Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer S Varambally, Q Cao, RS Mani, S Shankar, X Wang, B Ateeq, B Laxman, ... science 322 (5908), 1695-1699, 2008 | 1343 | 2008 |
| Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression JR Prensner, MK Iyer, OA Balbin, SM Dhanasekaran, Q Cao, JC Brenner, ... Nature biotechnology 29 (8), 742-749, 2011 | 1146 | 2011 |
| An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression J Yu, J Yu, RS Mani, Q Cao, CJ Brenner, X Cao, X Wang, L Wu, J Li, M Hu, ... Cancer cell 17 (5), 443-454, 2010 | 1014 | 2010 |
| Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ... Nature 448 (7153), 595-599, 2007 | 1004 | 2007 |
| Role of the TMPRSS2-ERG gene fusion in prostate cancer SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ... Neoplasia 10 (2), 177-IN9, 2008 | 888 | 2008 |
| The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao, L Patel, IA Vergara, ... Nature genetics 45 (11), 1392-1398, 2013 | 716 | 2013 |
| Repression of E-cadherin by the polycomb group protein EZH2 in cancer Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ... Oncogene 27 (58), 7274-7284, 2008 | 658 | 2008 |
| Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ... Nature medicine 16 (7), 793-798, 2010 | 550 | 2010 |
| Mechanistic rationale for inhibition of poly (ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer JC Brenner, B Ateeq, Y Li, AK Yocum, Q Cao, IA Asangani, S Patel, ... Cancer cell 19 (5), 664-678, 2011 | 475 | 2011 |
| The role of SPINK1 in ETS rearrangement-negative prostate cancers SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ... Cancer cell 13 (6), 519-528, 2008 | 402 | 2008 |
| Characterization of TMPRSS2: ETV5 and SLC45A3: ETV5 gene fusions in prostate cancer BE Helgeson, SA Tomlins, N Shah, B Laxman, Q Cao, JR Prensner, ... Cancer research 68 (1), 73-80, 2008 | 354 | 2008 |
| PCAT-1, a Long Noncoding RNA, Regulates BRCA2 and Controls Homologous Recombination in Cancer JR Prensner, W Chen, MK Iyer, Q Cao, T Ma, S Han, A Sahu, R Malik, ... Cancer research 74 (6), 1651-1660, 2014 | 284 | 2014 |
| Integrative genomics analysis reveals silencing of β-adrenergic signaling by polycomb in prostate cancer J Yu, Q Cao, R Mehra, B Laxman, J Yu, SA Tomlins, CJ Creighton, ... Cancer cell 12 (5), 419-431, 2007 | 271 | 2007 |
| The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc JR Prensner, W Chen, S Han, MK Iyer, Q Cao, V Kothari, JR Evans, ... Neoplasia 16 (11), 900-908, 2014 | 258 | 2014 |
| Polycomb-and methylation-independent roles of EZH2 as a transcription activator J Kim, Y Lee, X Lu, B Song, KW Fong, Q Cao, JD Licht, JC Zhao, J Yu Cell reports 25 (10), 2808-2820. e4, 2018 | 257 | 2018 |
| Coordinated regulation of polycomb group complexes through microRNAs in cancer Q Cao, RS Mani, B Ateeq, SM Dhanasekaran, IA Asangani, JR Prensner, ... Cancer cell 20 (2), 187-199, 2011 | 238 | 2011 |
| N6-Methyladenosine Modulates Nonsense-Mediated mRNA Decay in Human Glioblastoma F Li, Y Yi, Y Miao, W Long, T Long, S Chen, W Cheng, C Zou, Y Zheng, ... Cancer research 79 (22), 5785-5798, 2019 | 198 | 2019 |
| AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist DR Rhodes, B Ateeq, Q Cao, SA Tomlins, R Mehra, B Laxman, ... Proceedings of the National Academy of Sciences 106 (25), 10284-10289, 2009 | 190 | 2009 |
